Epratuzumab (Anti-Siglec-2 / CD22)
Product Specifications
CAS Number
205923-57-5
Synonyms
Antibody hLL 2
Additionnal Information
Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400994-500 1x 500 µL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940035-100 1x 100 µL
Calgranulin B / MRP-8/-14 / MAC 387 / S100A8/A9 / Macrophage Ag (MAC387), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040501-100 1x 100 µL
Progesterone Receptor (PR501), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042166-100 1x 100 µL
CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2166R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details